Metapneumovirus surge strains hospitals amidst winter risk
Chinese doctors have reported a sharp increase in metapneumovirus (hMPV) infections, which the national medical authorities have confirmed. According to the Independent, the rise in infections mainly affects children under 14 years old and is particularly noticeable in northern China.
Recordings on social media show overwhelmed hospitals, reminiscent of the early days of the COVID-19 pandemic. However, Beijing reassures the public that the increase in infections is typical for winter. Symptoms of the infection include high fever, cough, and sore throat, and in some cases, it can lead to bronchitis or pneumonia.
Viruses such as metapneumovirus (hMPV), alongside concurrent influenza and RSV infections, raise epidemiological concerns worldwide. There is no vaccine or specific medication for hMPV, which is already causing numerous hospitalisations due to acute bronchitis.
Viruses like hMPV are characterised by a tendency to mutate, making it difficult to control and predict the course of the epidemic.
Experts warn that viral infections can lead to severe complications, particularly during the autumn and winter. The possibility of co-infection with influenza, RSV, and metapneumovirus presents additional challenges for healthcare, as it places a greater strain on the immune system and increases the risk of complications in patients.
Neighbouring countries react. WHO has made a decision
Neighbouring countries like Hong Kong and India are monitoring the situation. Hong Kong has reported several cases of hMPV, while India has not noted an increase in respiratory illnesses. In Iran, medical authorities reassured that there was no cause for concern, and the WHO did not consider the situation to require special action.
The most affected are children and the elderly, who, due to weakened immune systems, are more susceptible to severe illness progression. The rise in hospitalisations due to respiratory illnesses necessitates that healthcare systems are prepared to meet patient needs and implement new epidemic management strategies.
